Released Nov 5, 2026, after the close
10-Q filed Nov 5, 2026, 36 days after period end · 0001559053-26-000031
On November 5, 2026, Prothena Corporation plc issued a press release announcing its financial results for the third quarter ended September 30, 2026.
The release| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $620.00K | $2.42M | $970.00K | $84.87M |
| Net Income | -$16.51M | -$36.54M | -$59.00M |
Prothena Corp Public Ltd Co · CIK 1559053 · Engraved from SEC EDGAR
| $21.91M |
| EPS Diluted | -$0.32 | -$0.68 | -$1.10 | $0.38 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prothena reported a third quarter 2026 net loss of $16.5 million, or $0.32 per share, compared with a net loss of $36.5 million in the third quarter of 2025.¶2
Total revenue was $0.6 million for the third quarter of 2026 and $52.7 million for the first nine months of 2026, including $50.0 million in milestone payment from Novo.¶3
As of September 30, 2026, Prothena had $272.2 million in cash, cash equivalents and restricted cash, and no debt.¶4
Prothena repurchased an aggregate of 2,745,380 ordinary shares during the first nine months of 2026 with $26.6 million, excluding commissions and expenses, under its up to $100.0 million share repurchase program.¶5
The company continues to expect full year 2026 net cash used in operating and investing activities of $18 to $23 million and a net loss of $25 to $30 million.¶6